First Time Loading...

Bioventix PLC
LSE:BVXP

Watchlist Manager
Bioventix PLC Logo
Bioventix PLC
LSE:BVXP
Watchlist
Price: 4 600 GBX Market Closed
Updated: Apr 20, 2024

Intrinsic Value

Bioventix Plc engages in the development and supply of antibodies. [ Read More ]

The intrinsic value of one BVXP stock under the Base Case scenario is 2 821.06 GBX. Compared to the current market price of 4 600 GBX, Bioventix PLC is Overvalued by 39%.

Key Points:
BVXP Intrinsic Value
Base Case
2 821.06 GBX
Overvaluation 39%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Bioventix PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BVXP stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Bioventix PLC

Provide an overview of the primary business activities
of Bioventix PLC.

What unique competitive advantages
does Bioventix PLC hold over its rivals?

What risks and challenges
does Bioventix PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bioventix PLC.

Provide P/S
for Bioventix PLC.

Provide P/E
for Bioventix PLC.

Provide P/OCF
for Bioventix PLC.

Provide P/FCFE
for Bioventix PLC.

Provide P/B
for Bioventix PLC.

Provide EV/S
for Bioventix PLC.

Provide EV/GP
for Bioventix PLC.

Provide EV/EBITDA
for Bioventix PLC.

Provide EV/EBIT
for Bioventix PLC.

Provide EV/OCF
for Bioventix PLC.

Provide EV/FCFF
for Bioventix PLC.

Provide EV/IC
for Bioventix PLC.

Show me price targets
for Bioventix PLC made by professional analysts.

What are the Revenue projections
for Bioventix PLC?

How accurate were the past Revenue estimates
for Bioventix PLC?

What are the Net Income projections
for Bioventix PLC?

How accurate were the past Net Income estimates
for Bioventix PLC?

What are the EPS projections
for Bioventix PLC?

How accurate were the past EPS estimates
for Bioventix PLC?

What are the EBIT projections
for Bioventix PLC?

How accurate were the past EBIT estimates
for Bioventix PLC?

Compare the revenue forecasts
for Bioventix PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bioventix PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bioventix PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bioventix PLC compared to its peers.

Compare the P/E ratios
of Bioventix PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Bioventix PLC with its peers.

Analyze the financial leverage
of Bioventix PLC compared to its main competitors.

Show all profitability ratios
for Bioventix PLC.

Provide ROE
for Bioventix PLC.

Provide ROA
for Bioventix PLC.

Provide ROIC
for Bioventix PLC.

Provide ROCE
for Bioventix PLC.

Provide Gross Margin
for Bioventix PLC.

Provide Operating Margin
for Bioventix PLC.

Provide Net Margin
for Bioventix PLC.

Provide FCF Margin
for Bioventix PLC.

Show all solvency ratios
for Bioventix PLC.

Provide D/E Ratio
for Bioventix PLC.

Provide D/A Ratio
for Bioventix PLC.

Provide Interest Coverage Ratio
for Bioventix PLC.

Provide Altman Z-Score Ratio
for Bioventix PLC.

Provide Quick Ratio
for Bioventix PLC.

Provide Current Ratio
for Bioventix PLC.

Provide Cash Ratio
for Bioventix PLC.

What is the historical Revenue growth
over the last 5 years for Bioventix PLC?

What is the historical Net Income growth
over the last 5 years for Bioventix PLC?

What is the current Free Cash Flow
of Bioventix PLC?

Financials

Balance Sheet Decomposition
Bioventix PLC

Current Assets 12m
Cash & Short-Term Investments 5.5m
Receivables 5.9m
Other Current Assets 585.7k
Non-Current Assets 1.1m
Long-Term Investments 610k
PP&E 522.7k
Current Liabilities 1.7m
Accounts Payable 1.7m
Non-Current Liabilities 6.7k
Other Non-Current Liabilities 6.7k
Efficiency

Earnings Waterfall
Bioventix PLC

Revenue
13.6m GBP
Cost of Revenue
-850.5k GBP
Gross Profit
12.7m GBP
Operating Expenses
-2m GBP
Operating Income
10.8m GBP
Other Expenses
-2.1m GBP
Net Income
8.7m GBP

Free Cash Flow Analysis
Bioventix PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

BVXP Profitability Score
Profitability Due Diligence

Bioventix PLC's profitability score is 86/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive Gross Profit
86/100
Profitability
Score

Bioventix PLC's profitability score is 86/100. The higher the profitability score, the more profitable the company is.

BVXP Solvency Score
Solvency Due Diligence

Bioventix PLC's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Bioventix PLC's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BVXP Price Targets Summary
Bioventix PLC

Wall Street analysts forecast BVXP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BVXP is 6 018 GBX with a low forecast of 5 959 GBX and a high forecast of 6 195 GBX.

Lowest
Price Target
5 959 GBX
30% Upside
Average
Price Target
6 018 GBX
31% Upside
Highest
Price Target
6 195 GBX
35% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

BVXP Price
Bioventix PLC

1M 1M
+0%
6M 6M
+25%
1Y 1Y
+22%
3Y 3Y
+24%
5Y 5Y
+35%
10Y 10Y
+1 024%
Annual Price Range
4 600
52w Low
3 500
52w High
5 060
Price Metrics
Average Annual Return 7.81%
Standard Deviation of Annual Returns 29.95%
Max Drawdown -35%
Shares Statistics
Market Capitalization 240.1m GBX
Shares Outstanding 5 219 660
Percentage of Shares Shorted
N/A

BVXP Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Bioventix PLC Logo
Bioventix PLC

Country

United Kingdom

Industry

Biotechnology

Market Cap

240.1m GBP

Dividend Yield

3.37%

Description

Bioventix Plc engages in the development and supply of antibodies. The company is headquartered in Farnham, Surrey and currently employs 17 full-time employees. The company went IPO on 2014-04-29. The principal activity of the Company is the development and supply of antibodies. The firm specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics, such as in automated immunoassays used in blood testing. The firm offers a portfolio of antibodies to customers for both commercial use and research and development (R&D) purposes, for the diagnosis or monitoring of a range of conditions, including heart disease, cancer, fertility, thyroid function and drug abuse. The firm also supplies antibody products and services to multinational clinical diagnostics companies. The firm sells its products through direct sales and through distributors.

Contact

SURREY
Farnham
7 Romans Business Park, East Street
+441252728001.0
http://www.bioventix.com/

IPO

2014-04-29

Employees

17

Officers

CEO & Director
Mr. Peter John Harrison MA
CFO & Director
Mr. Bruce Edward Heath Hiscock

See Also

Discover More
What is the Intrinsic Value of one BVXP stock?

The intrinsic value of one BVXP stock under the Base Case scenario is 2 821.06 GBX.

Is BVXP stock undervalued or overvalued?

Compared to the current market price of 4 600 GBX, Bioventix PLC is Overvalued by 39%.